Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity.

MLA

Posadas-Sánchez, Rosalinda, et al. “Dipeptidylpeptidase-4 Levels and DPP4 Gene Polymorphisms in Patients with COVID-19. Association with Disease and with Severity.” Life Sciences, vol. 276, July 2021, p. 119410. EBSCOhost, https://doi.org/10.1016/j.lfs.2021.119410.

APA

Posadas-Sánchez, R., Sánchez-Muñoz, F., Guzmán-Martín, C. A., Hernández-Díaz Couder, A., Rojas-Velasco, G., Fragoso, J. M., & Vargas-Alarcón, G. (2021). Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity. Life Sciences, 276, 119410. https://doi.org/10.1016/j.lfs.2021.119410

Chicago

Posadas-Sánchez, Rosalinda, Fausto Sánchez-Muñoz, Carlos Alfonso Guzmán-Martín, Adrian Hernández-Díaz Couder, Gustavo Rojas-Velasco, José Manuel Fragoso, and Gilberto Vargas-Alarcón. 2021. “Dipeptidylpeptidase-4 Levels and DPP4 Gene Polymorphisms in Patients with COVID-19. Association with Disease and with Severity.” Life Sciences 276 (July): 119410. doi:10.1016/j.lfs.2021.119410.